Evidence map›Paper›PMID 39475186›Full record

ArticleNucleic acids research2024

Alternative substrate kinetics of SARS-CoV-2 Nsp15 endonuclease reveals a specificity landscape dominated by RNA structure.

Nidhi Kalia, Kimberly C Snell, Michael E Harris

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nidhi KaliaDepartment of Chemistry, University of Florida, Gainesville, FL, 32611, USA.
Kimberly C SnellDepartment of Chemistry, University of Florida, Gainesville, FL, 32611, USA.
Michael E HarrisDepartment of Chemistry, University of Florida, Gainesville, FL, 32611, USA.ORCID 0000-0001-8977-4392

Funding

Specificity in Substrate Recognition and Catalysis by RNA Processing EnzymesR35GM127100 · NIGMS · UNIVERSITY OF FLORIDA · PI HARRIS, MICHAEL E. · 2018 to 2022
$1.6M
NIGMS NIH HHS R35 GM127100NIH HHS GM127100
6 · The paper itself

Abstract

Coronavirus endoribonuclease Nsp15 contributes to the evasion of host innate immunity by suppressing levels of viral dsRNA. Nsp15 cleaves both ssRNA and dsRNA in vitro with a strong preference for unpaired or bulged U residues, and its activity is stimulated by divalent ions. Here, we systematically quantified effects of RNA sequence and structure context that define its specificity. The results show that sequence preference for U↓A/G, observed previously, contributes only ca. 2-fold to kcat/Km. In contrast, dsRNA structure flanking a bulged U residue increases kcat/Km by an order of magnitude compared to ssRNA while base pairing in dsRNA essentially blocks cleavage. Despite enormous differences in multiple turnover kinetics, the effect of RNA structure on the cleavage step is minimal. Surprisingly, although divalent ion activation of Nsp15 is widely considered to be important for its biological function, the effect on kcat/Km is only ∼2-fold and independent of RNA structure. These results reveal a specificity landscape dominated by RNA structure and provide a quantitative framework for identifying interactions that underlie specificity, determining mechanisms of inhibition and resistance and defining targets important for coronavirus biology.

Indexed as

EndoribonucleasesNucleic Acid ConformationRNA, ViralSARS-CoV-2HumansKineticsRNA, Double-StrandedSubstrate SpecificityViral Nonstructural ProteinsEndoribonucleasesnidoviral uridylate-specific endoribonucleaseRNA, Double-StrandedRNA, ViralViral Nonstructural Proteins

Identifiers

PMID39475186
PMCPMC11602132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.